日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO-10-27

用于治疗脊髓性肌萎缩症的候选药物 BIO101 可作为单药疗法或与反义寡核苷酸 ASO-10-27 联合使用

Bézier, Cynthia; Cottin, Steve; Hashemi, Parvin Nazari; El Khoury, Mirella; Clerc, Zoé; Balducci, Christine; Sapaly, Delphine; Weill, Laure; Lafont, René; Veillet, Stanislas; Dilda, Pierre J; Charbonnier, Frédéric; Latil, Mathilde; Biondi, Olivier

A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults.

一项针对健康青年和老年人的 BIO101(20-羟基蜕皮激素)安全性和药代动力学的 1 期研究

Dioh Waly, Tourette Cendrine, Del Signore Susanna, Daudigny Louiza, Dupont Philippe, Balducci Christine, Dilda Pierre J, Lafont René, Veillet Stanislas

Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD).

BIO203 是一种新型诺比辛酰胺缀合物,正在开发用于治疗年龄相关性黄斑变性 (AMD),其具有抗炎作用、光保护和神经保护特性

Fontaine Valérie, Balducci Christine, Dinan Laurence, Monteiro Elodie, Boumedine Thinhinane, Fournié Mylène, Nguyen Vincent, Guibout Louis, Clatot Justine, Latil Mathilde, Veillet Stanislas, Sahel José-Alain, Lafont René, Dilda Pierre J, Camelo Serge

Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo

Norbixin在体外和体内均能保护视网膜色素上皮细胞和感光细胞免受A2E介导的光毒性损伤。

Fontaine, Valérie; Monteiro, Elodie; Brazhnikova, Elena; Lesage, Laëtitia; Balducci, Christine; Guibout, Louis; Feraille, Laurence; Elena, Pierre-Paul; Sahel, José-Alain; Veillet, Stanislas; Lafont, René